The Only Branded Topical Prescription Rosacea Treatment That's Available in
a Pump
METROGEL (metronidazole) Gel, 1% Pump is a unique topical rosacea treatment delivery system. In a survey, most patients preferred a pump over a tube.*
Claims based on a Consumer Packaging Preference Study of 207 physician-diagnosed, male and female rosacea patients aged 25 to 65 years. Patients were asked to complete a self-administered Internet survey following video presentations highlighting the steps involved when applying medication from a pump and a tube.


Indication: METROGEL® 1% is indicated for the topical treatment of the inflammatory lesions of rosacea. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (>2%) in patients treated with METROGEL 1% were nasopharyngitis, upper respiratory tract infection, and headache. Other adverse experiences reported when using topical metronidazole include skin irritation, transient redness, metallic taste, tingling or numbness of the extremities and nausea. Warnings/Precautions: METROGEL 1% should not be used by patients who are allergic to metronidazole or any ingredient in METROGEL 1%. Avoid contact of METROGEL 1% with the eyes as it may cause tearing. METROGEL 1% should be used with caution in patients with evidence of, or a history of, blood dyscrasia, and with patients taking blood thinning agents as they may experience prolonged prothrombin times. METROGEL 1% treatment should be discontinued if numbness or paresthesia of any extremity should occur.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.